Youcare Pharmaceutical Receives China Clinical Trial Nod for Nebulized Inhaler
Youcare Pharmaceutical (SHA:688658) obtained clinical trial approval from China's National Medical Products Administration for the YKYY017 nebulized inhaler.The drug is indicated for coronavirus infections, according to a Thursday filing with the Shanghai bourse.